Paid Clinical Trials Washington, D.C.

Discover 798 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 798

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Washington DC, Baltimore MD, Frederick MD, Norfolk VAshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

KC002Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Recruiting

PHASE2

Sponsor:

KeraCure

Location:

Washington DC, Baltimore MD, York PA, Souderton PAshow 17 more

Code:

NCT00330265

Conditions

Foot Ulcer

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KC-002

Conventional Wound Therapy

Olutasidenib & TemozolomideStudy of Olutasidenib and Temozolomide in HGG

Recruiting

PHASE2

Sponsor:

Rigel Pharmaceuticals

Location:

Washington DC, Philadelphia PA, Durham NC, Columbus OHshow 8 more

Code:

NCT06161974

Conditions

High Grade Glioma

Astrocytoma

Astrocytoma, Grade III

Astrocytoma, Grade IV

Diffuse Intrinsic Pontine Glioma

Eligibility Criteria

Sex: All

Age: 12 - 39

Healthy Volunteers: Not accepted

Interventions

Olutasidenib + TMZ

Exparel vs. BupivacainePost-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo

Recruiting

PHASE2

Sponsor:

Georgetown University

Location:

Washington DC

Code:

NCT03504865

Conditions

Mastectomy

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Liposomal bupivacaine

Standard bupivacaine

Placebo

Thoracotomy vs. ThoracoscopicThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Washington DC, Bethesda MD, Falls Church VA, Baltimore MDshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

IMC-F106C & Checkpoint InhibitorsSafety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Recruiting

PHASE1

PHASE2

Sponsor:

Immunocore Ltd

Location:

Washington DC, Philadelphia PA, Pittsburgh PA, New York NYshow 18 more

Code:

NCT04262466

Conditions

Select Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Brenetafusp

Brenetafusp and pembrolizumab

Brenetafusp and chemotherapy

Brenetafusp and monoclonal antibodies and chemotherapy

Brenetafusp and tebentafusp

Combination ChemotherapyCombination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

Recruiting

PHASE3

Sponsor:

University of Leicester

Location:

Washington DC, Falls Church VA, Baltimore MD, Hershey PAshow 88 more

Code:

NCT00020566

Conditions

Sarcoma

Eligibility Criteria

Sex: All

Age: 0 - 49

Healthy Volunteers: Not accepted

Interventions

dactinomycin

busulfan

doxorubicin hydrochloride

etoposide

ifosfamide

CamizestrantAn Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Washington DC, Bethesda MD, Fairfax VA, Annapolis MDshow 143 more

Code:

NCT05952557

Conditions

Breast Cancer, Early Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camizestrant

Tamoxifen

Anastrozole

Letrozole

Exemestane

Selumetinib vs. Carboplatin/VincristineA Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Washington DC, Bethesda MD, Baltimore MD, Richmond VAshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

BMS-986278A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Washington DC, Falls Church VA, Baltimore MD, Towson MDshow 87 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

Drug HolidayChanges in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates

Recruiting

Sponsor:

National Bone Health Alliance

Location:

Washington DC

Code:

NCT02575157

Conditions

Osteoporosis

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

No intervention